Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting

Rimas V. Lukas*, Steven J. Chmura, Ian F. Parney, Aaron Mammoser, Sonali M. Smith, Jing Li

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


In the following brief report, we highlight the advances in the neuro-oncology space from the ASCO 2022 Annual Meeting. We put into context the phase 2 and 3 trials and how these may alter the standard of care going forward. In addition, we highlight some other earlier work that will lead to future and potentially practice-changing trials.

Original languageEnglish (US)
Pages (from-to)552-558
Number of pages7
JournalNeuro-Oncology Practice
Issue number6
StatePublished - Dec 1 2022


  • brain metastases
  • glioblastoma
  • glioma
  • leptomeningeal metastases
  • meeting report
  • neuro-oncology

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Neurology


Dive into the research topics of 'Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting'. Together they form a unique fingerprint.

Cite this